ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267025.1	Avagacestat	Head and neck squamous cell carcinoma	0.015135125	Resistant
ENSG00000267025.1	Avagacestat	Breast invasive carcinoma	0.01892546	Sensitive